Therese Bittermann, MD, MSCE

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
BA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

I care for patients with viral hepatitis, auto-immune diseases of the liver, fatty liver disease, liver tumors, and cirrhosis. I also have expertise in pre- and post-transplantation management.

Description of Research Expertise

I study the relationship between immunosuppression strategy and outcomes after liver transplantation. I have previous expertise in research related to organ allocation, the effects of transplant policymaking and center variability in patient care. I have an advanced degree in clinical epidemiology, and have expertise with observational study designs, large databases and statistics.

Selected Publications

Bittermann T, Goldberg DS: Quantifying the effect of transplanting older donor livers into younger recipients: the need for donor-recipient age matching. Transplantation 102(12): 2033-7, Dec 2018.

Bittermann T: Physical activity after solid organ transplantation: comprehensive guidance is needed to advance future research efforts. Transplantation Nov 2018 Notes: Epub ahead of print.

Lee GS, Anesi JA, Besharatian BD, Bittermann T, Hamel S, Goldberg, DS: Con: Use of Hepatitis C Virus–Positive Donors Should Be Restricted to Research Protocols. Clinical Liver Disease 12(4): 105-8, Nov 2018.

Doshi SD, Wood L, Abt PL, Olthoff KM, Shaked A, Goldberg DS, Bittermann T: Outcomes of living donor liver transplantation using grafts heterozygous for alpha-1 antitrypsin gene mutations. Transplantation Oct 2018 Notes: Epub ahead of print.

Bittermann T, Prenner SB, Abt PL, Goldberg DS: Outcomes of liver transplantation for hepatic epithelioid hemangioendothelioma in the US (2002-2015). American Transplant Congress (ASTS & AST); Seattle, WA June 2018 Notes: Poster presentation.

Bittermann T, Wood L, Abt PL, Shaked A, Olthoff KM, Goldberg DS: Living liver donation is safe in donors heterozygous for an alpha-1 antitrypsin gene mutation. American Transplant Congress (ASTS & AST); Seattle, WA June 2018 Notes: Poster presentation.

Serper M, Bittermann T*, Rossi M, Goldberg DS, Thomasson AM, Olthoff KM, Shaked A: Functional status, healthcare utilization, and the costs of liver transplantation. American Journal of Transplantation 18(5): 1187-96, May 2018 Notes: *co-first author.

Bittermann T, Hubbard RA, Serper M, Lewis JD, Hohmann SF, VanWagner LB, Goldberg DS: Healthcare utilization after liver transplantation is highly variable among both centers and recipients. American Journal of Transplantation 18(5): 1197-1205, May 2018.

Nazarian SM, Peng AW, Duggirala B, Gupta M, Bittermann T, Amaral S, Levine MH: The kidney allocation system does not appropriately stratify risk of pediatric donor kidneys: Implications for pediatric recipients. American Journal of Transplantation 18(3): 574-9, Mar 2018.

Bittermann T, Weinberg E: Complete Response of Diffuse Large B Cell Lymphoma After Direct-Acting Antiviral Therapy for Hepatitis C Virus. Clin Gastroenterol Hepatol Feb 2018 Notes: Epub ahead of print.

back to top
Last updated: 05/10/2019
The Trustees of the University of Pennsylvania